Monte Rosa Therapeutics, Inc. (GLUE) Profit Margin
Monte Rosa Therapeutics, Inc. (GLUE) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | -96.14% |
| 2025-12-31 | -31.23% |
How GLUE compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | 30.16% |
| ARWR | Arrowhead Pharmaceuticals Inc. | -0.20% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| ARVN | Arvinas Inc. | -30.77% |
| IDYA | IDEAYA Biosciences Inc. | -51.99% |
These are five companies in the same sector as GLUE with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Monte Rosa Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("GLUE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GLUE | $15.95 | +1.21% | 0.27M |
| 3 | ||||
| 4 | ||||
| 5 |